Skip to content

Homeopathic treatment of anemia

Lecithinum 6CH in iron deficiency anemia in reproductive age group women: Evaluation by double-blind, randomized, placebo-controlled pilot trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038880
Enrollment
60
Registered
2021-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

Intervention1: Lecithinum 6CH: Intervention is planned administering Lecithinum 6CH, twice a day for 3 months. Each dose will consist of 4 globules (no. 40) of cane sugar, medicated with a single drop

Sponsors

D N De Homoeopathic Medical College Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from iron deficiency anaemia (IDA) confirmed by Hb% 7-12 gm/dl and serum ferritin level less than 30 ng/mL. 2. Reproductive age group: 18-49 years 3. Only female 4. Patient taking iron supplement will be advised to stop the supplement for 14 days, followed by re-assessment of blood markers in the next enrollment. 5. Literate patients; ability to read and write in Bengali and/or English.

Exclusion criteria

Exclusion criteria: 1. Patients with hemoglobin less than 7 gm/dL (severe anemia) 2. Diagnosed case of unstable mental or physical illness or other uncontrolled systemic illness or life- threatening infections (e.g., malignancy) affecting quality of life or any vital organ failure 3. Pregnant, puerperal and lactational women 4. Patient under tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence 5. Self-reported immune-compromised state 6. Undergoing homeopathic treatment for any chronic diseases within last 6 months

Design outcomes

Primary

MeasureTime frame
Serum ferritin levelTimepoint: Baseline and after 3 months

Secondary

MeasureTime frame
Blood hemoglobin levelTimepoint: Baseline and after 3 months;Serum ironTimepoint: Baseline and after 3 months;Total iron binding capacity (TIBC)Timepoint: Baseline and after 3 months;Unsaturated iron binding capacity (UIBC)Timepoint: Baseline and after 3 months;Complete hemogramTimepoint: Baseline and after 3 months;Peripheral blood smearTimepoint: Baseline and after 3 months;Fatigue severity scale (FSS) scoreTimepoint: Baseline and after 3 months

Countries

India

Contacts

Public ContactShubhamoy Ghosh

D N De Homoeopathic Medical College and Hospital

indranihalder2020@gmail.com7001295073

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026